Tyra Biosciences (TYRA) EBITDA (2020 - 2026)

Quarterly EBITDA fell 40.25% to -$39.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$131.7 million through Mar 2026, down 37.54% year-over-year, with the annual reading at -$120.3 million for FY2025, 39.76% down from the prior year.

Tyra Biosciences filings provide 7 years of EBITDA readings, the most recent being -$39.6 million for Q1 2026.

  • EBITDA hit -$39.6 million in Q1 2026 for Tyra Biosciences, down from -$33.9 million in the prior quarter.
  • Across five years, EBITDA topped out at -$11.9 million in Q1 2023 and bottomed at -$39.6 million in Q1 2026.
  • Average EBITDA over 5 years is -$22.0 million, with a median of -$21.2 million recorded in 2023.
  • The largest annual shift saw EBITDA plummeted 252.27% in 2022 before it rose 19.91% in 2023.
  • Tyra Biosciences' EBITDA stood at -$15.0 million in 2022, then plummeted by 49.48% to -$22.4 million in 2023, then fell by 18.28% to -$26.6 million in 2024, then dropped by 27.61% to -$33.9 million in 2025, then decreased by 16.85% to -$39.6 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's EBITDA are -$39.6 million (Q1 2026), -$33.9 million (Q4 2025), and -$29.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -13.63 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.14 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 661.60 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.82 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 201.19 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - -39.59 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -39.59 Mn
Dec 31, 2025 -33.88 Mn
Sep 30, 2025 -29.86 Mn
Jun 30, 2025 -28.35 Mn
Mar 31, 2025 -28.23 Mn
Dec 31, 2024 -26.55 Mn
Sep 30, 2024 -22.08 Mn
Jun 30, 2024 -18.88 Mn
Mar 31, 2024 -18.58 Mn
Dec 31, 2023 -22.45 Mn
Sep 30, 2023 -21.15 Mn
Jun 30, 2023 -13.27 Mn
Mar 31, 2023 -11.88 Mn
Dec 31, 2022 -15.02 Mn
Sep 30, 2022 -13.65 Mn
Jun 30, 2022 -15.43 Mn
Mar 31, 2022 -14.83 Mn
Dec 31, 2021 -9.93 Mn
Sep 30, 2021 -6.64 Mn
Jun 30, 2021 -5.51 Mn
Mar 31, 2021 -4.21 Mn
Dec 31, 2020 -3.68 Mn
Sep 30, 2020 -2.33 Mn